Vandetanib inhibits cisplatin‑resistant neuroblastoma tumor growth and invasion

Changchun Li1, Chao Yang1, Guanghui Wei2

  • 1Department of Pediatric Surgical Oncology, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing 400014, P.R. China.

Oncology Reports
|February 14, 2018
PubMed

Insights

Vandetanib shows promise for treating cisplatin-resistant neuroblastoma (NB). This drug inhibits cancer cell growth and invasion, offering a potentially less toxic alternative to high-dose cisplatin for NB therapy.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Biology

Background:

  • Cisplatin resistance is a primary obstacle in neuroblastoma (NB) treatment.
  • Vandetanib is an established therapeutic agent for various cancers.

Purpose of the Study:

  • To evaluate the efficacy of Vandetanib in overcoming cisplatin resistance in neuroblastoma.
  • To investigate the role of p-RET and CXCR4 in cisplatin-resistant NB.

Main Methods:

  • Immunohistochemistry (IHC) to assess p-RET and CXCR4 expression in NB tissues.
  • In vitro assays (CCK8, colony formation, invasion) on cisplatin-resistant SH-SY5Y cells.
  • In vivo studies using mouse models to evaluate tumor growth and toxicity.

Main Results:

  • Elevated p-RET and CXCR4 expression observed in cisplatin-resistant NB.
  • Vandetanib treatment significantly reduced proliferation, colony formation, and invasion of resistant NB cells.
  • Vandetanib demonstrated comparable efficacy to high-dose cisplatin in reducing tumor growth with lower liver toxicity.

Conclusions:

  • Vandetanib effectively targets cisplatin-resistant neuroblastoma cells by downregulating p-RET and CXCR4.
  • Vandetanib presents a promising therapeutic option for cisplatin-resistant NB, with a favorable toxicity profile.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.4K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.1K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.9K
Population Growth00:57

Population Growth

Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K